ZUG, Switzerland -- Foster Wheeler AG (Nasdaq: FWLT) announced today that its India subsidiary, Foster Wheeler India Private Limited, part of its Global Engineering and Construction Group, has been awarded a contract for...
Pharmacogenetic Patents Have the Potential to Extend Drug Candidate's Potential Commercial Exclusivity Period If Regulatory Approval Obtained BROOMFIELD, Colo. -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular...
ZUG, Switzerland -- Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Power Group has been awarded a contract by Yuen Foong Yu Paper Mfg. (Yangzhou) Co., Ltd. for...
NEWARK, N.J. -- McCarter & English LLP has elected nine new partners in its offices in Newark, Boston, Hartford and Wilmington, effective as of January 1, 2012. The new partners practice in a...
ZUG, Switzerland -- Foster Wheeler (NASDAQ: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by Petron Corporation (Petron) for the Petron Refinery Master...
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of...
Everyone holds a piece of the pro-business, pro-growth puzzle: consumers, government and the private sector all have a role to play in rebuilding our economy. As a member of the Senate Banking and...
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/318c2f/france_pharmaceuti) has announced the addition of the "France Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. Despite the government's focus on fiscal consolidation - which includes...
SALT LAKE CITY -- Idaho Technology, Inc. (ITI) is pleased to announce that U.S. Patent Application No. 12/067,642, titled "Melting Curve Analysis with Exponential Background Subtraction," issued November 28, 2011 as U.S. Patent...
SUNNYVALE, Calif. -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting...
Federal Circuit affirms importance of investment in drug research and development BALTIMORE -- Celsis In Vitro, Inc. (Celsis IVT) announced today that the United States Court of Appeals for the Federal Circuit in...
ROCKVILLE, Md. -- RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the Company" or "RegeneRx") today announced that it has been issued a patent from the U.S. Patent and Trademark Office claiming methods for...
IP Coverage for Head and Neck, Lung Cancer Patient Selection and Monitoring BROOMFIELD, Colo. -- Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced the issuance of three...
NEW YORK -- Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) announced that it has acted as a Co-Manager to its client Vical Incorporated...
TUCSON, Ariz. -- BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection[TM], announced today that it has changed its name to Azbil BioVigilant, Inc. The name change reflects the Company's alignment with its...
Granted New European Patent Encompasses Compositions and Use of PUR118 for Treatment of COPD, CF and Other Respiratory Diseases LEXINGTON, Mass. -- Pulmatrix, a clinical stage biotechnology company discovering and developing a new...
ZUG, Switzerland -- Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Power Group has completed the purchase of Graf-Wulff GmbH, a German company that designs, manufactures and installs...
ZUG, Switzerland -- Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Power Group has been given a limited notice to proceed (LNTP) for the design and supply of...
-- Biogen Idec has Option to Develop and Commercialize Promising Compound for Most Common Genetic Cause of Infant Mortality -- -- Biogen Idec's Expertise in Neurology to Aid in Rapid Development of ISIS-SMN...
ZUG, Switzerland -- Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Power Group has been given a limited notice to proceed (LNTP) by GS Engineering and Construction for...